Skip to main content
Premium Trial:

Request an Annual Quote

So Complex

Newsweek discusses some of "life's complexities," namely epigenetics and systems biology.

One article takes a look at epigenetics and its role in cancer. A few epigenetic cancer drugs have been approved by FDA, such as Vidaza and Zolinza, but "first-generation epigenetic drugs have not included a home run like Gleevec," the story says.

In that same issue, Lee Hood describes his vision of P4 medicine — predictive, personalized, preventive, and participatory. Soon, he says, with just a pinprick of blood, thousands of tests may be run and the results sent to both the patient and the doctor. "The new P4 medicine will eventually lead to a universal democratization of health care, bringing to billions the fundamental right of health, unimaginable even a few years ago," Hood writes. He points out, though, that to reach this goal, changes will have to be made to medical education, research, and to the insurance and pharmaceutical industries.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.